Pediatrix Medical Group (NYSE:MD) Raised to Strong-Buy at Wall Street Zen

Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Saturday.

MD has been the topic of several other research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Pediatrix Medical Group in a research note on Saturday, September 27th. UBS Group boosted their price objective on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Leerink Partners boosted their price objective on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a research note on Friday, September 5th. Finally, Zacks Research raised shares of Pediatrix Medical Group to a “strong-buy” rating in a research note on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group currently has an average rating of “Hold” and an average price target of $16.79.

Pediatrix Medical Group Price Performance

Shares of NYSE MD opened at $17.52 on Friday. Pediatrix Medical Group has a 1 year low of $11.59 and a 1 year high of $17.77. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.80 and a quick ratio of 1.80. The company’s 50-day moving average is $15.82 and its 200 day moving average is $14.41. The stock has a market capitalization of $1.53 billion, a P/E ratio of 13.58 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business had revenue of $468.84 million for the quarter, compared to analyst estimates of $464.37 million. During the same quarter in the previous year, the firm posted $0.34 earnings per share. Pediatrix Medical Group’s quarterly revenue was down 7.1% on a year-over-year basis. On average, sell-side analysts expect that Pediatrix Medical Group will post 1.38 earnings per share for the current year.

Hedge Funds Weigh In On Pediatrix Medical Group

Several institutional investors have recently bought and sold shares of the business. California State Teachers Retirement System lifted its position in Pediatrix Medical Group by 0.9% during the fourth quarter. California State Teachers Retirement System now owns 80,327 shares of the company’s stock valued at $1,054,000 after purchasing an additional 752 shares during the last quarter. AlphaQuest LLC lifted its holdings in Pediatrix Medical Group by 16.0% during the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company’s stock valued at $85,000 after buying an additional 811 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its holdings in shares of Pediatrix Medical Group by 8.7% in the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,913 shares of the company’s stock valued at $171,000 after purchasing an additional 950 shares in the last quarter. SummerHaven Investment Management LLC raised its holdings in shares of Pediatrix Medical Group by 0.9% in the 1st quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company’s stock valued at $1,628,000 after purchasing an additional 1,028 shares in the last quarter. Finally, New York State Common Retirement Fund grew its position in shares of Pediatrix Medical Group by 1.7% in the 2nd quarter. New York State Common Retirement Fund now owns 62,245 shares of the company’s stock worth $893,000 after buying an additional 1,034 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.